Publications by authors named "S M Chandi"
Revision total knee arthroplasty (rTKA) is an increasingly common challenge for arthroplasty surgeons. The survivorship of rTKA is significantly lower than that of primary total knee arthroplasty, resulting in increasing numbers of repeat rTKA. These repeat rTKAs present unique challenges including potentially massive bone loss and increased risk of infection.
View Article and Find Full Text PDFIntroduction: Manipulation under anesthesia (MUA) is a first-line treatment for stiffness after total knee arthroplasty (TKA), but predicting outcomes after MUA can be difficult.
Purpose: We sought to determine the association between pre-MUA range-of-motion (ROM) and the risk of repeat MUA and revision in patients who underwent primary TKA.
Methods: We conducted a retrospective review of 543 MUAs for stiffness at a single institution.
Article Synopsis
- Extensor mechanism disruption is a serious complication following total knee arthroplasty (TKA), and there is currently no agreed-upon treatment strategy for it.
- A study involving 41 cases of acute extensor mechanism disruptions showed that the two-year survivorship free from reoperation was significantly higher for primary TKA compared to revision TKA.
- The findings revealed that primary repair with or without augmentation offered poor early survivorship and there was no significant improvement in patient-reported outcomes, indicating a need for better counseling for patients facing these complications.
Background: The purpose of this study was to determine implant survivorship and functional outcomes for revision total knee arthroplasty (rTKA) with contemporary rotating-hinge knee implants.
Methods: A retrospective review identified 115 rTKAs using contemporary rotating-hinge implants from 2014 to 2018 for the treatment of instability (34, 30%), reimplantation after periprosthetic joint infection (PJI) (33, 29%), aseptic loosening (25, 22%), arthrofibrosis (14, 12%), periprosthetic fracture (4, 3%), osteolysis (4, 3%), and femoral component fracture (1, 1%). There were 70 women (61%), and the mean age was 67 years (range, 27 to 94).
Cardiovascular diseases (CVDs), including ischemic heart disease and stroke, are the leading cause of mortality worldwide, causing nearly 20 million deaths annually. Traditional therapies, while effective, have not curbed the rising prevalence of CVDs driven by aging populations and lifestyle factors. This review highlights innovative therapeutic strategies that show promise in improving patient outcomes and transforming cardiovascular care.
View Article and Find Full Text PDF